Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biotin-dependent enzymes are a family of enzymes that utilize the vitamin biotin as a covalently bound prosthetic group (cofactor) for catalyzing key metabolic reactions, primarily carboxylation, but also decarboxylation and transcarboxylation[1][4][5][6]. The most well-characterized members in humans are the carboxylases: acetyl-CoA carboxylase, propionyl-CoA carboxylase, pyruvate carboxylase, methylcrotonyl-CoA carboxylase, and (in some taxa) geranyl-CoA carboxylase[1][2][3]. These enzymes are essential for processes such as fatty acid synthesis, gluconeogenesis, branch-chain amino acid metabolism, and other anaplerotic pathways[2][3][5]. Structurally, they share a conserved biotin-binding domain that facilitates the transfer of a carboxyl group between substrates via a swinging-arm mechanism[4][5]. Biotin-dependent enzymes are ancient, with conserved domains across all domains of life[4]. In humans, their deficiency leads to serious metabolic disorders, often responsive to biotin supplementation. In addition to their metabolic roles, biotinylation of non-enzymatic proteins such as histones can affect gene expression and chromatin stability[1][2]. Key notes: - "Biotin-dependent enzymes" refers to a family, not a single entity; for disease or drug targeting, it is crucial to specify which member or deficiency is relevant[4][1]. - There are no canonical abbreviations for the family as a whole; individual enzymes have recognized abbreviations (e.g., ACC, PCC, PC, MCC)[1][3]. - Direct pharmacological modulation is limited to dietary supplementation; enzyme deficiencies are most relevant therapeutically[2].
Cofactor supplementation (biotin restores activity of deficient biotin-dependent enzymes). No established small-molecule drugs directly modulate their activity in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biotin-dependent enzyme.